Zhengye Net Income From Continuing Ops from 2010 to 2026
| ZYBT Stock | 1.15 0.01 0.88% |
Net Income From Continuing Ops | First Reported 2010-12-31 | Previous Quarter 12.1 M | Current Value 11.5 M | Quarterly Volatility 13.8 M |
Check Zhengye Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zhengye Biotechnology's main balance sheet or income statement drivers, such as Tax Provision of 790 K, Interest Income of 211.5 K or Depreciation And Amortization of 22.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0. Zhengye financial statements analysis is a perfect complement when working with Zhengye Biotechnology Valuation or Volatility modules.
Zhengye | Net Income From Continuing Ops | Build AI portfolio with Zhengye Stock |
Latest Zhengye Biotechnology's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Zhengye Biotechnology Holding over the last few years. It is Zhengye Biotechnology's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zhengye Biotechnology's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Zhengye Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 40,468,521 | |
| Geometric Mean | 36,705,180 | |
| Coefficient Of Variation | 34.09 | |
| Mean Deviation | 10,265,321 | |
| Median | 46,467,000 | |
| Standard Deviation | 13,794,036 | |
| Sample Variance | 190.3T | |
| Range | 44.2M | |
| R-Value | (0.65) | |
| Mean Square Error | 116.9T | |
| R-Squared | 0.42 | |
| Significance | 0 | |
| Slope | (1,778,630) | |
| Total Sum of Squares | 3044.4T |
Zhengye Net Income From Continuing Ops History
About Zhengye Biotechnology Financial Statements
Zhengye Biotechnology shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Zhengye Biotechnology investors may analyze each financial statement separately, they are all interrelated. The changes in Zhengye Biotechnology's assets and liabilities, for example, are also reflected in the revenues and expenses on on Zhengye Biotechnology's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 12.1 M | 11.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Zhengye Stock Analysis
When running Zhengye Biotechnology's price analysis, check to measure Zhengye Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhengye Biotechnology is operating at the current time. Most of Zhengye Biotechnology's value examination focuses on studying past and present price action to predict the probability of Zhengye Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhengye Biotechnology's price. Additionally, you may evaluate how the addition of Zhengye Biotechnology to your portfolios can decrease your overall portfolio volatility.